News
Presidio Pharmaceuticals, Inc. to Present at the JMP Securities and BioPartnering Europe Healthcare Conferences
SAN FRANCISCO-(Business Wire)-October 2, 2008 - Presidio Pharmaceuticals, Inc. announced today that Mr. Leo Redmond, Chief Financial Officer at Presidio will be presenting an overview of Presidio and an update to its HCV and HIV programs at the Third Annual JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 3:30 PM, to be held at the Le Parker Meridien Hotel in New York.
In addition, the company’s President and Chief Executive Officer, Dr. Omar K. Haffar, will be presenting at the 16th Annual BioPartnering Europe conference on Monday, October 13th at 12 pm. The meeting will be held at the Queen Elizabeth II Conference Centre in London, UK.
About Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel therapeutics for viral infections, including HCV and HIV-1. Presidio has raised over $27 million in financing from Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West, Nexus Medical Partners, and Sagamore Bioventures LLC. For more information, please visit our website at www.presidiopharma.com.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
